Afrodite Lourbakos

Afrodite Lourbakos currently serves as the Director of Translational Medicine at FibroGen, Inc. since December 2023. Prior experience includes Senior Director of Translational Medicine at ORYN THERAPEUTICS, LLC, and various leadership roles in translational sciences and biomarker research at Allogene Therapeutics, Akoya Biosciences, Merus, BioMarin Pharmaceutical Inc., and Prosensa BV. Afrodite has a strong educational foundation with a Ph.D. in Biochemistry and Cell Biology from Monash University, along with additional degrees in teaching, honors in Biochemistry, and a Bachelor's in Biochemistry and Chemistry from the University of Tasmania.